000 | 02960 a2200757 4500 | ||
---|---|---|---|
005 | 20250515053600.0 | ||
264 | 0 | _c20070327 | |
008 | 200703s 0 0 eng d | ||
022 | _a1524-4571 | ||
024 | 7 |
_a10.1161/01.RES.0000258023.76515.a3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTing, Harold J | |
245 | 0 | 0 |
_aTriglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. _h[electronic resource] |
260 |
_bCirculation research _cFeb 2007 |
||
300 |
_a381-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAorta |
650 | 0 | 4 |
_aAortic Diseases _xetiology |
650 | 0 | 4 |
_aApolipoprotein C-III _xmetabolism |
650 | 0 | 4 |
_aArteriosclerosis _xetiology |
650 | 0 | 4 |
_aArteritis _xetiology |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 |
_aCell Adhesion Molecules _xmetabolism |
650 | 0 | 4 |
_aCells, Cultured _xdrug effects |
650 | 0 | 4 |
_aChylomicrons _xblood |
650 | 0 | 4 |
_aDietary Fats _xadministration & dosage |
650 | 0 | 4 |
_aE-Selectin _xbiosynthesis |
650 | 0 | 4 | _aEndocytosis |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
650 | 0 | 4 |
_aFat Emulsions, Intravenous _xpharmacology |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertriglyceridemia _xblood |
650 | 0 | 4 | _aHypoglycemia |
650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xbiosynthesis |
650 | 0 | 4 |
_aLDL-Receptor Related Protein-Associated Protein _xpharmacology |
650 | 0 | 4 |
_aLDL-Receptor Related Proteins _xdrug effects |
650 | 0 | 4 |
_aLeukocytes _xcytology |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
650 | 0 | 4 |
_aLipoproteins, VLDL _xblood |
650 | 0 | 4 |
_aLow Density Lipoprotein Receptor-Related Protein-1 _xdrug effects |
650 | 0 | 4 |
_aMembrane Transport Proteins _xdrug effects |
650 | 0 | 4 | _aModels, Cardiovascular |
650 | 0 | 4 |
_aMonocytes _xcytology |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 |
_aReceptors, LDL _xdrug effects |
650 | 0 | 4 | _aRheology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTriglycerides _xblood |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xbiosynthesis |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
700 | 1 | _aStice, James P | |
700 | 1 | _aSchaff, Ulrich Y | |
700 | 1 | _aHui, David Y | |
700 | 1 | _aRutledge, John C | |
700 | 1 | _aKnowlton, Anne A | |
700 | 1 | _aPasserini, Anthony G | |
700 | 1 | _aSimon, Scott I | |
773 | 0 |
_tCirculation research _gvol. 100 _gno. 3 _gp. 381-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.RES.0000258023.76515.a3 _zAvailable from publisher's website |
999 |
_c16798829 _d16798829 |